A note on the length-biased Weibull-Gamma frailty survival model
Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Giussani, A. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis - John, Binu V. ELSEVIER, 2022, Amsterdam |
|---|---|
| Übergeordnetes Werk: |
volume:153 ; year:2019 ; pages:32-36 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.spl.2019.05.009 |
|---|
| Katalog-ID: |
ELV047418311 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047418311 | ||
| 003 | DE-627 | ||
| 005 | 20230624134603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.spl.2019.05.009 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000697.pica |
| 035 | |a (DE-627)ELV047418311 | ||
| 035 | |a (ELSEVIER)S0167-7152(19)30138-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.87 |2 bkl | ||
| 100 | 1 | |a Giussani, A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A note on the length-biased Weibull-Gamma frailty survival model |
| 264 | 1 | |c 2019 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. | ||
| 650 | 7 | |a Length-biased survival analysis |2 Elsevier | |
| 650 | 7 | |a Survival analysis |2 Elsevier | |
| 650 | 7 | |a Frailty model |2 Elsevier | |
| 700 | 1 | |a Bonetti, M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a John, Binu V. ELSEVIER |t Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |d 2022 |g Amsterdam |w (DE-627)ELV008609586 |
| 773 | 1 | 8 | |g volume:153 |g year:2019 |g pages:32-36 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.spl.2019.05.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.87 |j Gastroenterologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 153 |j 2019 |h 32-36 |g 5 | ||
| author_variant |
a g ag |
|---|---|
| matchkey_str |
giussaniabonettim:2019----:ntoteeghisdeblgmari |
| hierarchy_sort_str |
2019 |
| bklnumber |
44.87 |
| publishDate |
2019 |
| allfields |
10.1016/j.spl.2019.05.009 doi GBV00000000000697.pica (DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.87 bkl Giussani, A. verfasserin aut A note on the length-biased Weibull-Gamma frailty survival model 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier Bonetti, M. oth Enthalten in Elsevier Science John, Binu V. ELSEVIER Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis 2022 Amsterdam (DE-627)ELV008609586 volume:153 year:2019 pages:32-36 extent:5 https://doi.org/10.1016/j.spl.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.87 Gastroenterologie VZ AR 153 2019 32-36 5 |
| spelling |
10.1016/j.spl.2019.05.009 doi GBV00000000000697.pica (DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.87 bkl Giussani, A. verfasserin aut A note on the length-biased Weibull-Gamma frailty survival model 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier Bonetti, M. oth Enthalten in Elsevier Science John, Binu V. ELSEVIER Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis 2022 Amsterdam (DE-627)ELV008609586 volume:153 year:2019 pages:32-36 extent:5 https://doi.org/10.1016/j.spl.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.87 Gastroenterologie VZ AR 153 2019 32-36 5 |
| allfields_unstemmed |
10.1016/j.spl.2019.05.009 doi GBV00000000000697.pica (DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.87 bkl Giussani, A. verfasserin aut A note on the length-biased Weibull-Gamma frailty survival model 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier Bonetti, M. oth Enthalten in Elsevier Science John, Binu V. ELSEVIER Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis 2022 Amsterdam (DE-627)ELV008609586 volume:153 year:2019 pages:32-36 extent:5 https://doi.org/10.1016/j.spl.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.87 Gastroenterologie VZ AR 153 2019 32-36 5 |
| allfieldsGer |
10.1016/j.spl.2019.05.009 doi GBV00000000000697.pica (DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.87 bkl Giussani, A. verfasserin aut A note on the length-biased Weibull-Gamma frailty survival model 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier Bonetti, M. oth Enthalten in Elsevier Science John, Binu V. ELSEVIER Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis 2022 Amsterdam (DE-627)ELV008609586 volume:153 year:2019 pages:32-36 extent:5 https://doi.org/10.1016/j.spl.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.87 Gastroenterologie VZ AR 153 2019 32-36 5 |
| allfieldsSound |
10.1016/j.spl.2019.05.009 doi GBV00000000000697.pica (DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.87 bkl Giussani, A. verfasserin aut A note on the length-biased Weibull-Gamma frailty survival model 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier Bonetti, M. oth Enthalten in Elsevier Science John, Binu V. ELSEVIER Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis 2022 Amsterdam (DE-627)ELV008609586 volume:153 year:2019 pages:32-36 extent:5 https://doi.org/10.1016/j.spl.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.87 Gastroenterologie VZ AR 153 2019 32-36 5 |
| language |
English |
| source |
Enthalten in Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis Amsterdam volume:153 year:2019 pages:32-36 extent:5 |
| sourceStr |
Enthalten in Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis Amsterdam volume:153 year:2019 pages:32-36 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Gastroenterologie |
| institution |
findex.gbv.de |
| topic_facet |
Length-biased survival analysis Survival analysis Frailty model |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |
| authorswithroles_txt_mv |
Giussani, A. @@aut@@ Bonetti, M. @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008609586 |
| dewey-sort |
3610 |
| id |
ELV047418311 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047418311</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624134603.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.spl.2019.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000697.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047418311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-7152(19)30138-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.87</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giussani, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A note on the length-biased Weibull-Gamma frailty survival model</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Length-biased survival analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Frailty model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonetti, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">John, Binu V. ELSEVIER</subfield><subfield code="t">Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV008609586</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:153</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:32-36</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.spl.2019.05.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.87</subfield><subfield code="j">Gastroenterologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">153</subfield><subfield code="j">2019</subfield><subfield code="h">32-36</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| author |
Giussani, A. |
| spellingShingle |
Giussani, A. ddc 610 bkl 44.87 Elsevier Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model A note on the length-biased Weibull-Gamma frailty survival model |
| authorStr |
Giussani, A. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008609586 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.87 bkl A note on the length-biased Weibull-Gamma frailty survival model Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model Elsevier |
| topic |
ddc 610 bkl 44.87 Elsevier Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model |
| topic_unstemmed |
ddc 610 bkl 44.87 Elsevier Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model |
| topic_browse |
ddc 610 bkl 44.87 Elsevier Length-biased survival analysis Elsevier Survival analysis Elsevier Frailty model |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m b mb |
| hierarchy_parent_title |
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |
| hierarchy_parent_id |
ELV008609586 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008609586 |
| title |
A note on the length-biased Weibull-Gamma frailty survival model |
| ctrlnum |
(DE-627)ELV047418311 (ELSEVIER)S0167-7152(19)30138-5 |
| title_full |
A note on the length-biased Weibull-Gamma frailty survival model |
| author_sort |
Giussani, A. |
| journal |
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |
| journalStr |
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
32 |
| author_browse |
Giussani, A. |
| container_volume |
153 |
| physical |
5 |
| class |
610 VZ 44.87 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Giussani, A. |
| doi_str_mv |
10.1016/j.spl.2019.05.009 |
| dewey-full |
610 |
| title_sort |
a note on the length-biased weibull-gamma frailty survival model |
| title_auth |
A note on the length-biased Weibull-Gamma frailty survival model |
| abstract |
Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. |
| abstractGer |
Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. |
| abstract_unstemmed |
Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
A note on the length-biased Weibull-Gamma frailty survival model |
| url |
https://doi.org/10.1016/j.spl.2019.05.009 |
| remote_bool |
true |
| author2 |
Bonetti, M. |
| author2Str |
Bonetti, M. |
| ppnlink |
ELV008609586 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.spl.2019.05.009 |
| up_date |
2024-07-06T22:50:18.974Z |
| _version_ |
1803871813868978176 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047418311</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624134603.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.spl.2019.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000697.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047418311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-7152(19)30138-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.87</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giussani, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A note on the length-biased Weibull-Gamma frailty survival model</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Univariate length-biased survival data has been extensively treated in the statistical literature, and its importance has been shown under cross-sectional sampling of prevalent cases. In this article, we discuss frailty length-biased data models, and derive some specific quantities and relationships.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Length-biased survival analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Frailty model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonetti, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">John, Binu V. ELSEVIER</subfield><subfield code="t">Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV008609586</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:153</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:32-36</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.spl.2019.05.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.87</subfield><subfield code="j">Gastroenterologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">153</subfield><subfield code="j">2019</subfield><subfield code="h">32-36</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.397485 |